Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals

PURPOSE: Cyclosporine A (CsA) is the most widely used immunosuppressive agent after a hematopoietic stem cell transplantation (HSCT). Although recommendations for CsA dose conversion from intravenous to oral administration differ from 1:1 to 1:3, most studies did not consider the role of azole antif...

Descripción completa

Detalles Bibliográficos
Autores principales: Atiq, Ferdows, Hameli, Edon, Broers, Annoek E. C., Doorduijn, Jeanette K., Van Gelder, Teun, Andrews, Louise M., Koch, Birgit C. P., Versmissen, Jorie, de Winter, Brenda C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Pharmacokinetics and Disposition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942354/
https://www.ncbi.nlm.nih.gov/pubmed/29500599
http://dx.doi.org/10.1007/s00228-018-2434-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942354/
https://www.ncbi.nlm.nih.gov/pubmed/29500599
http://dx.doi.org/10.1007/s00228-018-2434-4

Ejemplares similares